Lynn D. Kramer

The AHEAD 3–45 Study: Design of a prevention trial for Alzheimer’s disease

Keith A. Johnson, R. Sperling, P. Aisen, 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.

A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody

D. Berry, J. Cummings, L. Lannfelt, 2020, Alzheimer's Research & Therapy.

Consistency of efficacy results across various clinical measures and statistical methods in the lecanemab phase 2 trial of early Alzheimer’s disease

D. Berry, Scott Berry, C. Swanson, 2022, Alzheimer's research & therapy.

Lecanemab in Early Alzheimer's Disease.

R. Bateman, B. Vellas, C. V. van Dyck, 2022, The New England journal of medicine.

Alzheimer's disease pathology in the neocortex and hippocampus of the western lowland gorilla (Gorilla gorilla gorilla)

Patrick R Hof, Chet C Sherwood, Mary Ann Raghanti, 2013, The Journal of comparative neurology.

The β-Secretase BACE1 in Alzheimer’s Disease

B. de Strooper, H. Hampel, S. Lista, 2020, Biological Psychiatry.